These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9329539)
1. New treatments and azathioprine in multiple sclerosis. Kolar OJ Lancet; 1997 Oct; 350(9083):1033. PubMed ID: 9329539 [No Abstract] [Full Text] [Related]
2. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
3. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together. Messori A; Fadda V; Maratea D; Trippoli S J Neurol Sci; 2014 Dec; 347(1-2):408-10. PubMed ID: 25455308 [No Abstract] [Full Text] [Related]
4. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort. Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204 [TBL] [Abstract][Full Text] [Related]
5. [Multiple sclerosis--recent advances in pathogenesis and treatment]. Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352 [No Abstract] [Full Text] [Related]
6. Multiple sclerosis. Boggild M; Ford H Clin Evid; 2003 Jun; (9):1459-73. PubMed ID: 15366193 [No Abstract] [Full Text] [Related]
7. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Bojar M; Zajac M; Meluzínová E; Houžvičková E; Libertinová J; Lišková P; Mat'oška V; Nyč O; Mináriková M Mult Scler; 2010 Dec; 16(12):1529-30; author reply 1531-2. PubMed ID: 20829243 [No Abstract] [Full Text] [Related]
8. [Pragmatic approach to treatments in multiple sclerosis]. Vermersch P Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F125-31. PubMed ID: 19593885 [No Abstract] [Full Text] [Related]
9. Multiple sclerosis. Ford H; Nicholas R Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466 [No Abstract] [Full Text] [Related]
10. New treatments for multiple sclerosis. Hutchinson M Ir Med J; 1996; 89(2):44. PubMed ID: 8682623 [No Abstract] [Full Text] [Related]
12. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis. Goodkin DE West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569 [TBL] [Abstract][Full Text] [Related]
13. New treatments and azathioprine in multiple sclerosis. Palace J; Rothwell P Lancet; 1997 Jul; 350(9073):261. PubMed ID: 9242805 [No Abstract] [Full Text] [Related]
14. [Therapeutic potential of interferon beta-1b and related drugs in multiple sclerosis: comparative meta-analysis]. Cendrowski W Neurol Neurochir Pol; 2001; 35(4 Suppl):125-38. PubMed ID: 11873611 [TBL] [Abstract][Full Text] [Related]
15. Non-specific immunosuppressants in the treatment of multiple sclerosis. Confavreux C; Vukusic S Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781 [TBL] [Abstract][Full Text] [Related]
16. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Ravnborg M; Bendtzen K; Christensen O; Jensen PE; Hesse D; Tovey MG; Sørensen PS Mult Scler; 2009 Mar; 15(3):323-8. PubMed ID: 19028832 [TBL] [Abstract][Full Text] [Related]
17. How should we proceed with disease-modifying treatments for multiple sclerosis? Andersson PB; Waubant E; Goodkin DE Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726 [No Abstract] [Full Text] [Related]